THERAPEUTIC FORMULATIONS AND USES THEREOF
Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are de...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
06.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
L'invention concerne des compositions pharmaceutiquement acceptables contenant un inhibiteur sélectif de la cyclo-oxygénase-2 (COX-2) (coxib) et éventuellement de la buprénorphine. En particulier, l'invention concerne des compositions contenant un coxib formulé pour une administration orale, topique ou sous-cutanée pour traiter la douleur ou l'inflammation. |
---|---|
Bibliography: | Application Number: WO2020US57899 |